Cumming, CA, United States of America

Alka Potdar

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alka Potdar: Innovator in Inflammatory Disease Treatment

Introduction

Alka Potdar is a notable inventor based in Cumming, California, recognized for her contributions to the field of medical treatment for inflammatory diseases. With a focus on innovative methods and systems, she has made significant strides in identifying suitable treatments for patients suffering from conditions such as Crohn's disease and primary sclerosing cholangitis.

Latest Patents

Alka Potdar holds a patent for "Methods and systems for selection and treatment of patients with inflammatory diseases." This patent describes methods for identifying subjects who are suitable for treatment with an inhibitor of CD30L activity or expression, such as an anti-CD30L antibody. The methods disclosed in her patent are designed to identify subjects based on the presence of a genotype indicative of a disease or condition for which an inhibitor of CD30L is an appropriate treatment.

Career Highlights

Throughout her career, Alka Potdar has worked with esteemed organizations, including Cedars-Sinai Medical Center and Prometheus Biosciences, Inc. Her work has been instrumental in advancing the understanding and treatment of inflammatory diseases.

Collaborations

Alka has collaborated with notable professionals in her field, including Janine M. Bilsborough and Dermot P. McGovern. These collaborations have contributed to her innovative approaches and successful patent applications.

Conclusion

Alka Potdar's work in the field of inflammatory diseases showcases her dedication to improving patient outcomes through innovative treatment methods. Her patent and collaborations highlight her significant contributions to medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…